Efficacy of adalimumab therapy in patients with Crohn's disease who were unresponsive to or intolerant of infliximab: 6 years of experience in a single gastroenterology center.

被引：0
|
作者：
Shafran, I [1 ]
Cangemi, D. [1 ]
Burgunder, P. [1 ]
机构：
[1] Shafran Gastroenterol Ctr, Winter Pk, FL USA
来源：
INFLAMMATORY BOWEL DISEASES | 2011年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S62 / S63
页数：2
相关论文
共 50 条
  • [31] Clinical experience with infliximab therapy in 100 patients with Crohn's disease
    Farrell, RJ
    Shah, SA
    Lodhavia, PJ
    Alsahli, M
    Falchuk, KR
    Michetti, P
    Peppercorn, MA
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (12): : 3490 - 3497
  • [32] Response after 12 weeks of adalimumab therapy in patients with Crohn's disease who were nonresponders at week 4
    Panaccione, Remo
    Sandborn, William
    Colombel, Jean Fred
    Pollack, Paul
    Chen, Naijun
    Chao, Jingdong
    Mulani, Parvez
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S379 - S379
  • [33] Safety and efficacy of infliximab therapy in HIV patients with Crohn's disease
    Tessnow, K
    Chiao, L
    Jamjian, C
    Ries, K
    GASTROENTEROLOGY, 2002, 122 (04) : A616 - A616
  • [34] Impact of Adalimumab therapy after 12 Weeks in patients with Crohn's Disease who were nonresponders at week 4
    Panaccione, R.
    Sandborn, W.
    Colombel, J.
    Pollack, P.
    Chen, N.
    Chao, J.
    Mulani, P.
    INFLAMMATORY BOWEL DISEASES, 2008, 14 (12) : S28 - S28
  • [35] The safety and efficacy of adalimumab in patients with Crohn's disease: the experience of a single Canadian tertiary care centre
    Teriaky, Anouar
    Gregor, James
    Yan, Brian
    Ponich, Terry
    Chande, Nilesh
    Mosli, Mahmoud
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2014, 49 (03) : 280 - 286
  • [36] Adalimumab in the Treatment of Perianal Crohn's Disease: A Single Center in 64 Patients
    Gionchetti, Paolo
    Rizzello, Fernando
    Tambasco, Rosy
    Straforini, Giulia
    Brugnera, Ramona
    Calabrese, Carlo
    Poggioli, Gilberto
    Laureti, Silvio
    Campieri, Massimo
    GASTROENTEROLOGY, 2010, 138 (05) : S328 - S328
  • [37] Clinical experience with infliximab therapy in the initial 256 infusions in patients with Crohn's disease at the Crohn's and Colitis Center of New Jersey
    Glazier, KD
    Shirodkar, MA
    Kosa, E
    Mirza, ZK
    Griffel, LH
    Das, KM
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S262 - S262
  • [38] Evaluation of adalimumab therapy in multidisciplinary strategy for perianal Crohn's disease patients with infliximab failure
    Echarri, Ana
    Castro, Javier
    Barreiro, Manuel
    Carpio, Daniel
    Pereira, Santos
    Lorenzo, Aurelio
    JOURNAL OF CROHNS & COLITIS, 2010, 4 (06): : 654 - 660
  • [39] Efficacy and Safety of Certolizumab Pegol in patients with active Crohn's Disease who previously lost response or were intolerant to Infliximab: Open-Label induction results of the WELCOME Study
    Vermeire, S.
    Abreu, M.
    D'Haens, G.
    Colombel, J.
    Mitchev, K.
    Fedorak, R.
    Spehlmann, M.
    Lee, S.
    Sandborn, W.
    Rutgeerts, P.
    INFLAMMATORY BOWEL DISEASES, 2008, 14 (12) : S30 - S30
  • [40] Outcome of infliximab therapy in pediatric Crohn's disease: The first three years experience
    Sant'Anna, AMGA
    Gervais, F
    Deslandres, C
    Seidman, EG
    GASTROENTEROLOGY, 2004, 126 (04) : A458 - A459
12345